Prestige Imports Provides Competitive Comparisons for 2018 Karma Revero

NORTH MIAMI BEACH, Fla. (PRWEB) October 27, 2018

In North Miami Beach, Florida, there is an automotive dealership determined to get the word out about one of the youngest new vehicles available in its inventory. The 2018 Karma Revero is an incredibly new hybrid-electric vehicle from the young exotic car brand, which is a successor to the former automotive manufacturer Fisker.

With both the brand and vehicle being so fresh and new, the folks at Prestige Imports want to make sure residents of the greater Miami area and beyond are well aware that a hybrid-electric vehicle is an available option to them. To help spread the word, dealership staff has been providing plenty of information on its website and blog, including a number of competitive comparison pages that pit the 2018 Karma Revero against some of its biggest competitors.

The Revero is a vehicle in a segment of its own, in many ways, and so there aren't many direct competitors out there. Prestige Imports has made due, however, pitting it against competitors even remotely similar. Among the vehicles compared to are the BMW I8, Toyota Prius Prime, Tesla Model S and Aston Martin Rapide S.

Anyone that might be interested in learning more about the 2018 Karma Revero or how it compares to the competition are encouraged to check out the dealership's website at http://www.prestigeimports.com. More specific questions can be directed to the sales team by calling 888-860-5210. Prestige Imports is located at 15050 Biscayne Boulevard in North Miami Beach.

Read the full story at https://www.prweb.com/releases/prestige_imports_provides_competitive_comparisons_for_2018_karma_revero/prweb15871062.htm

You May Also Be Interested In

• Affordable Garage Door Repairs of Indianapolis, LLC Expands Trusted Garage Door Repair Services Across Indianapolis
• Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
• Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera